New York, NY -- (SBWIRE) -- 12/04/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Teekay Tankers Ltd (NYSE:TNK), Magnum Hunter Resources Corp (NYSE:MHR), Merck & Co., Inc (NYSE:MRK), Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Teekay Tankers Ltd (NYSE:TNK) the stock opened the session at $2.94 but then moved to $3.09. At that price, the stock showed a positive performance of 5.10%. Teekay Tankers Ltd. is an international provider of marine transportation to global oil industries. The Company’s business is to own crude oil and product tankers. The Company is wholly owned subsidiary of Teekay Corporation. The Company’s operations are managed by Teekay Tankers Management Services Ltd., a subsidiary of Teekay Corporation, which provides to it commercial, technical, administrative and strategic services. As of February 1, 2013, the Company’s fleet consisted of 30 vessels,
Will TNK Continue To Move Higher? Find Out Here
Magnum Hunter Resources Corp (NYSE:MHR) opened the session at $7.15 and closed the session at $6.99. The stock showed a negative performance of -3.19% in previous trading session. Traded with volume of 5.27 million shares in the prior session and the average volume of the stock remained 5.50 million shares. Magnum Hunter Resources Corporation (Magnum Hunter) is an independent oil and gas company engaged in the exploration for and the exploitation, acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the states of West Virginia, Ohio, Texas, Kentucky and North Dakota and in Saskatchewan, Canada.
Has MHR Found The Bottom And Ready To Gain Momentum? Find Out Here
Merck & Co., Inc (NYSE:MRK) opened the session at $49.82 and closed the session at $49.76. The stock showed a negative performance of -0.84% in previous trading session. Traded with volume of 13.61 million shares in the prior session and the average volume of the stock remained 13.77 million shares. The beta of the stock remained 0.34. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment,
Why Should Investors Buy MRK After the Recent Fall? Just Go Here and Find Out
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) the stock decreased -13.43% and finished the session at $1.74. Traded with volume of 272,811.00 shares in the prior session and the average volume of the stock remained 342,686.00 shares. The beta of the stock remained 10.78. InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries. The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries.
Will NVIV Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)